Market Access

Market Access is a function within pharmaceutical and biotechnology companies ensuring that the patients most likely to benefit from a new drug can access it, and that the drug is both cost-effective for healthcare systems and commercially viable for the manufacturer.

What is Market Access?

Market Access is a function within pharmaceutical and biotechnology companies responsible for ensuring that a new drug or treatment is available to patients in a particular market, typically by securing the necessary approvals, meeting regulatory requirements, and negotiating with Health Technology Assessment (HTA) bodies and payers (such as insurance companies or government healthcare systems) for coverage and reimbursement.

Market Access involves demonstrating the clinical and economic value of a product to various stakeholders, including HTA bodies, healthcare providers, payers and policymakers to gain favorable terms for distribution and pricing. It is a critical step in the commercialization of a pharmaceutical product, as successful market access ensures that the drug reaches the patients who need it while achieving the desired financial returns for the company.

Linked Resource here?
No spam. Just the latest releases and tips, interesting articles, and exclusive interviews in your inbox every week.
Read about our privacy policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.